Table of Contents Author Guidelines Submit a Manuscript
Journal of Chemistry
Volume 2017, Article ID 8281518, 7 pages
https://doi.org/10.1155/2017/8281518
Research Article

Synthesis and Antitumor Activity of Novel Pyridoxine-Based Bioisosteric Analogs of trans-Stilbenes

1Kazan (Volga Region) Federal University, Kremlyovskaya 18, Kazan 420008, Russia
2I.M. Sechenov First Moscow State Medical University, Trubetskaya 8, Bldg 2, Moscow 119991, Russia

Correspondence should be addressed to Yurii G. Shtyrlin; moc.liamg@nilryths.iiruy

Received 9 March 2017; Accepted 31 May 2017; Published 6 July 2017

Academic Editor: Ponnurengam Malliappan Sivakumar

Copyright © 2017 Mikhail V. Pugachev et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T.-Y. Shen, H. Jones, and C. P. Dorn, Mercaptoalkylpyridine Disulfides, U.S. Patent 4053606 A, 1977.
  2. Y.-C. Kim, K.-Y. Jung, and J. H. Cho, Novel Pyridine Carboxylic Acid Based Compound Used as a p2x1 and p2x3 Receptor Antagonist, a Production Method for the Same and a Composition Comprising the Same, U.S. Patent 20130040997, 2011.
  3. W. Korytnyk, S. C. Srivastava, N. Angelino, P. G. G. Potti, and B. Paul, “A general method for modifying the 2-methyl group of pyridoxol. Synthesis and biological activity of 2-vinyl- and 2-ethynylpyridoxols and related compounds,” Journal of Medicinal Chemistry, vol. 16, no. 10, pp. 1096–1101, 1973. View at Publisher · View at Google Scholar · View at Scopus
  4. M. V. Pugachev, N. V. Shtyrlin, L. P. Sysoeva et al., “Synthesis and antibacterial activity of novel phosphonium salts on the basis of pyridoxine,” Bioorganic and Medicinal Chemistry, vol. 21, no. 14, pp. 4388–4395, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. M. V. Pugachev, N. V. Shtyrlin, S. V. Sapozhnikov et al., “Bis-phosphonium salts of pyridoxine: the relationship between structure and antibacterial activity,” Bioorganic and Medicinal Chemistry, vol. 21, no. 23, pp. 7330–7342, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. A. D. Strelnik, A. S. Petukhov, I. V. Zueva et al., “Novel potent pyridoxine-based inhibitors of AChE and BChE, structural analogs of pyridostigmine, with improved in vivo safety profile,” Bioorganic and Medicinal Chemistry Letters, vol. 26, no. 16, pp. 4092–4094, 2016. View at Publisher · View at Google Scholar · View at Scopus
  7. M. V. Pugachev, R. S. Pavelyev, T. N. Nguyen, A. G. Iksanova, O. A. Lodochnikova, and Y. G. Shtyrlin, “Synthesis and antitumor activity of pyridoxine monoalkenyl derivatives,” Russian Chemical Bulletin, vol. 65, no. 2, pp. 532–536, 2016. View at Publisher · View at Google Scholar
  8. M. V. Pugachev, T. M. Bulatov, T. T. Nguyen et al., “Wittig reactions of a bis-triphenylphosphonium pyridoxine derivative,” Tetrahedron Letters, vol. 58, no. 8, pp. 766–769, 2017. View at Publisher · View at Google Scholar
  9. B. R. Stranix, J. J. Wu, G. Milot et al., “Pyridoxine hydroxamic acids as novel HIV-integrase inhibitors,” Bioorganic and Medicinal Chemistry Letters, vol. 26, no. 4, pp. 1233–1236, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. J.-X. Yu, W. Cui, V. A. Bourke, and R. P. Mason, “6-trifluoromethylpyridoxine: novel 19F NMR pH indicator for in vivo detection,” Journal of Medicinal Chemistry, vol. 55, no. 15, pp. 6814–6821, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. W. Zhang, J. Yao, V. Pham et al., “Pyridoxine as a template for the design of antiplatelet agents,” Bioorganic and Medicinal Chemistry Letters, vol. 14, no. 18, pp. 4747–4750, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. V. Pham, W. Zhang, V. Chen et al., “Design and synthesis of novel pyridoxine 5′-phosphonates as potential antiischemic agents,” Journal of Medicinal Chemistry, vol. 46, no. 17, pp. 3680–3687, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Turo, M. Smolski, R. Esler et al., “Diethylstilboestrol for the treatment of prostate cancer: Past, present and future,” Scandinavian Journal of Urology, vol. 48, no. 1, pp. 4–14, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. F. Li, J. Dou, L. Wei, S. Li, and J. Liu, “The selective estrogen receptor modulators in breast cancer prevention,” Cancer Chemotherapy and Pharmacology, vol. 77, no. 5, pp. 895–903, 2016. View at Publisher · View at Google Scholar · View at Scopus
  15. L. F. G. Rittie, Isolation and Culture of Skin Fibroblasts, Humana Press, Totowa, NJ, USA, 2010.
  16. A. Jameera Begam, S. Jubie, and M. Nanjan, “Estrogen receptor agonists/antagonists in breast cancer therapy: a critical review,” Bioorganic Chemistry, vol. 71, pp. 257–274, 2017. View at Publisher · View at Google Scholar
  17. N. Szydlowski, L. Bürkle, L. Pourcel, M. Moulin, J. Stolz, and T. B. Fitzpatrick, “Recycling of pyridoxine (vitamin B6) by PUP1 in Arabidopsis,” Plant Journal, vol. 75, no. 1, pp. 40–52, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Sharma, A. Verma, J. Singh et al., “Vitamin B6 tethered endosomal PH responsive lipid nanoparticles for triggered intracellular release of doxorubicin,” ACS Applied Materials and Interfaces, vol. 8, no. 44, pp. 30407–30421, 2016. View at Publisher · View at Google Scholar · View at Scopus